Why should you attend?
- To develop strategies aligning business and market access and activities
- Understand macro environmental health market realities
- To stay informed and updated of healthcare regulatory frameworks
- To learn how to manage upstream and downstream activities of HTA technology cycle
- To use HTA tools to effectively build a business case
Who should attend?
Any medical device company representative who is involved in introducing new health technologies to the market, including (but not limited to):
- Chief Executives,
- Managing Directors,
- Business Unit Managers,
- Product Managers,
- Marketing Managers and
- Market Access Managers.
Programme
Information session: 2 March 2023 - click to view recording
Where and how HTA can support patient access to innovation
Inviting all Medical Technology colleagues wishing to gain perspective on:
- Importance of using HTA for medical devices
- How HTA can promote patient access to innovative medical devices
- What role can industry play in expediting HTA decision making
Study Unit 1: Navigating the South African Healthcare Environment
Provide:
- Background to the SA Health Care industry.
- Useful industry demographic and economic indicators.
- Industry structure and relationships between stakeholders.
- Industry dynamics that are worth watching.
- Macro environmental factors that may influence your market.
- The ability to navigate market access hurdles and processes.
Contact session: 8 November 2023
Study Unit 2: Health Technology Assessment (HTA)
Provide:
- A framework for Health Technology Management (HTM) and managing the technology lifecycle
- How HTA offers a strategic approach to introducing new heath technologies.
- How HTA fits into the health technology regulatory framework of South Africa.
- A non-linear approach to managing introduction of health technologies.
- Insight into the 3 distinct components of HTM, pre HTA, HTA and post HTA and unpacking these in the context of your business.
Contact session: 16 November 2023
Study Unit 3: Developing a Market Access Strategy
Provide:
- Efficiently align business and reimbursement strategies
- A systematic approach to developing a market access strategy aligned with the company’s business strategy.
- An understanding of who the various stakeholders are in the decision-making process, their respective influence on each other and on your market access strategy.
- A framework for defining a meaningful value proposition to each relevant stakeholder.
- A guide on collating the information and creating the “dossier” for submission.
Contact session: 23 November 2023
6 Nov - 1 Dec 2023
3 weeks duration
Certificate
of completion awarded
15 hours
Study time
Fees (excl VAT)
R3740 Corp Members
R3975 Stand Members
R4210 Ind Members
R4675 Non Members3 live sessions
with Mark Brand via Zoom - 19h00-21h00
Meet the Course Developer and Author

Mark Brand
Independent HTA Consultant; MBA; Electrical Engineering; HTA (USB)
Click on image for bio
Scheduled Events
Please note that dates, topics and presenters are subject to change.
Latest Newsletter
Your information will be used as per the PTCMA Privacy Policy - by signing up for the PTCMA newsletter, you will receive monthly events updates, product notices and other PTCMA communication.